ArticleScientific reports2024

Analysis of US Food and Drug Administration new drug and biologic approvals, regulatory pathways, and review times, 1980-2022.

Enrique Seoane-Vazquez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.